Adjuvant CMFVP versus melphalan for operable breast cancer with positive axillary nodes: 10-year results of a Southwest Oncology Group Study
Rivkin, S E ; Green, S ; Metch, B ; Glucksberg, H ; Gad-el-Mawla, N ; Constanzi, J J ; Hoogstraten, B ; Athens, J ; Maloney, T ; Osborne, C K
Journal of clinical oncology, 1989-09, Vol.7 (9), p.1229-1238 [Periódico revisado por pares]United States: American Society of Clinical Oncology
Sem texto completo